Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence.-论文-万方医学网

作者： Dale N,Gerding ^[1] ; Ciaran P,Kelly ^[2] ; Galia,Rahav ^[3] ; Christine,Lee ^[4] ; Erik R,Dubberke ^[5] ; Princy N,Kumar ^[6] ; Bruce,Yacyshyn ^[7] ; Dina,Kao ^[8] ; Karen,Eves ^[9] ; Misoo C,Ellison ^[10] ; Mary E,Hanson ^[11] ; Dalya,Guris ^[12] ; Mary Beth,Dorr ^[10]

作者单位： Department of Veterans Affairs, Edward Hines Jr Veterans Affairs Hospital, Illinois. ^[1] Gastroenterology Division, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts. ^[2] Infectious Diseases, Sheba Medical Center, Tel Hashomer, and Sackler School of Medicine, Tel-Aviv University, Israel. ^[3] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver. ^[4] McMaster University, Hamilton, Ontario, Canada. ^[5] Division of Infectious Diseases, Washington University School of Medicine, St Louis, Missouri. ^[6] Division of Infectious Diseases and Travel Medicine, Georgetown University School of Medicine, Washington, D.C. ^[7] Division of Digestive Diseases, University of Cincinnati, Ohio. ^[8] Department of Medicine, Division of Gastroenterology, University of Alberta, Edmonton, Canada. ^[9] Clinical Research, Infectious Diseases, Kenilworth, New Jersey. ^[10] Late Development Statistics, Biostatistics, Kenilworth, New Jersey. ^[11] Global Scientific and Medical Publications, Infectious Diseases, Merck & Co, Inc, Kenilworth, New Jersey. ^[12]

主题词青少年(Adolescent);成年人(Adult);年龄因素(Age Factors);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗菌药(Anti-Bacterial Agents);抗体, 单克隆(Antibodies, Monoclonal);抗体, 中和(Antibodies, Neutralizing);梭菌感染(Clostridium Infections);女(雌)性(Female);人类(Humans);男(雄)性(Male);甲硝唑(Metronidazole);中年人(Middle Aged);病人再入院(Patient Readmission);复发(Recurrence);危险因素(Risk Factors);二级预防(Secondary Prevention);万古霉素(Vancomycin);青年人(Young Adult)

DOI 10.1093/cid/ciy171

PMID 29538686

发布时间 2022-03-30

检索历史清除

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence.

Clinical infectious diseases

相似文献

Clinical infectious diseases

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence.

Clinical infectious diseases

相似文献

Clinical infectious diseases

相关期刊

检索历史清除